Michael Rossi is President and Chief Executive Officer of Y-mAbs Therapeutics, Inc. (YMAB). The company reported total compensation of $4,557,590 for fiscal year 2024.
| Salary | $705,600 |
|---|---|
| Bonus | $0 |
| Stock awards | $1,170,732 |
| Option awards | $2,288,662 |
| Non-equity incentive plan | $392,596 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $0 |
| Total | $4,557,590 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Y-mAbs Therapeutics, Inc. filed May 30, 2025, accession 0001558370-25-008299.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2024 | President and Chief Executive Officer | $705,600 | $0 | $1,170,732 | $2,288,662 | $392,596 | $0 | $0 | $4,557,590 |
| FY2023 | President and Chief Executive Officer | $109,582 | $371,623 | $0 | $2,629,348 | $0 | $0 | $0 | $3,110,553 |
Totals as disclosed in each year's own compensation disclosure for Y-mAbs Therapeutics, Inc..
| Peer-group chief executive median | $4,484,715 |
|---|---|
| Difference from that median | $72,876 |
| Percentile within the disclosed peer group | 50th |
| Peers with a disclosed figure | 16 |
Medians and percentiles are computed across the peer group Y-mAbs Therapeutics, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2024 total |
|---|---|---|
| Michael Rossi this page | President and Chief Executive Officer | $4,557,590 |
| Peter Pfreundschuh | Executive Vice President, Chief Financial Officer and Treasurer | $2,504,717 |
| Thomas Gad | Founder, Chief Business Officer and Vice Chairman of the Board of Directors | $2,075,163 |
The company's named executive officers for fiscal year 2024, and what it reported for each. See the full Y-mAbs Therapeutics, Inc. compensation brief.
Michael Rossi's compensation sits inside Y-mAbs Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.